Ready for this week’s top pharma headlines so far? We bring you latest survey results on the adoption of machine learning by the industry, personnel shake-ups at GSK and Takeda, futuristic mutterings about organs being grown in space, and there’s no room at the inn and hiked costs for three quarters of warehousing firms among Brexit uncertainty. Have a read -
Interested in Star’s innovative outsourcing and resourcing solutions?
Contact Head of Business Development, Ryan Wooller, at email@example.com, or get in touch on 07748 464 079.
On the hunt for a new role, or just curious?
Visit our candidate page, submit your CV to firstname.lastname@example.org, or give our offices a ring!
Evidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase R&D efficiencies.
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just weeks after the firm announced it would split its business in two.
The man leading the UK and Ireland operations in what Takeda (TYO: 4502) calls the company’s ‘new phase’ will be Jon Neal, it has been confirmed.
Three-quarters of UK warehouse owners say their space is full to capacity and storage costs have soared by up to 25% in the past three months after a surge in Brexit-related inquiries.
Imagine a laboratory growing human hearts - and imagine that laboratory floating in space hundreds of miles above the surface of the Earth.
While you’re here…
…and are interested in our content, why not sign up to our newsletter? It’s just below here.